Sarepta Therapeutics SRPT
$13.33 −$0.84 (-5.93%)
Market closed · Nov 20, 8:10 pm ET · Last extended-hours $13.60 +2.03%
Open$13.92
Prev close$14.17
Day range$13.25 – $14.47
Volume2.25M
Market cap$1.43B
P/E (TTM)–
Dividend yield–
Fundamentals
Latest reported quarter: Q3, ended Sep 2026
Revenue$381.35M-4.5% YoY
Operating profit-$9.04M+85.6% YoY
Net profit-$28.46M+43.7% YoY
Diluted EPS-$0.27+46.0% YoY
Free cash flow$53.83M+226.4% YoY
Operating cash flow$59.97M
Revenue, last 8 quarters
Net profit, last 8 quarters
Diluted EPS by quarter
Free cash flow by quarter
Annual revenue
Profitability & balance sheet
Gross margin56.8%
Operating margin-0.4%
Net margin-5.9%
Return on equity-8.0%
Return on assets-3.4%
Return on invested capital-3.1%
Current ratio3.46
Liabilities / assets51.7%
Cash & investments$878.78M
Total debt$1.05B
Net cash (debt)-$174.25M
Free cash flow / sales8.8%
Where the revenue comes from
Quarter 2026/Q3
By business line
Income statement
| Line item | 2026 Q3 | 2026 Q2 | 2026 Q1 | 2025 ANNUAL | 2025 Q4 |
|---|---|---|---|---|---|
| Total Revenue as Reported | $381.35M | $401.25M | $730.80M | $2.20B | $442.93M |
| Total Operating Revenue | $381.35M | $401.25M | $730.80M | $2.20B | $442.93M |
| Cost of Revenue | $188.51M | $149.39M | $108.77M | $839.61M | $398.71M |
| Gross Profit | $192.84M | $251.87M | $622.04M | $1.36B | $44.23M |
| Operating Expense | $201.88M | $199.58M | $263.60M | $2.02B | $454.31M |
| Selling and Admin Expenses | $118.61M | $107.60M | $108.95M | $491.72M | $128.30M |
| -General & Admin Expense | $118.61M | $107.60M | $108.95M | $491.72M | $128.30M |
| Research & Development | $82.55M | $91.26M | $153.96M | $1.52B | $325.34M |
| Depreciation & Amortization & Depletion | $718,000.00 | $717,000.00 | $691,000.00 | $2.62M | $677,000.00 |
| -Depreciation & Amortization | $718,000.00 | $717,000.00 | $691,000.00 | $2.62M | $677,000.00 |
| Operating Profit | -$9.04M | $52.29M | $358.43M | -$657.77M | -$410.08M |
| Net Non-Operating Interest Income (Expense) | -$13.41M | -$14.35M | -$14.71M | -$1.45M | -$10.21M |
| Non-Operating Interest Income | $8.20M | $7.16M | $7.00M | $36.69M | $8.74M |
| Non-Operating Interest Expense | $21.62M | $21.51M | $21.71M | $38.14M | $18.95M |
| Other Income (Expense) | -$3.31M | -$39.69M | -$548,000.00 | -$43.00M | $12.62M |
| Gain on Sale of Security | -$523,000.00 | -$448,000.00 | -$1.71M | -$15.91M | $1.35M |
| Special Income (Charges) | $0.00 | -$39.00M | – | -$25.15M | $11.60M |
| -Less:Restructuring and Mergern & Acquisition | $0.00 | – | – | $42.01M | $1.50M |
| Other Non-Operating Income (Expenses) | -$2.79M | -$246,000.00 | $1.16M | -$1.94M | -$338,000.00 |
| Pretax Profit | -$25.77M | -$1.75M | $343.17M | -$702.23M | -$407.68M |
| Tax | $2.70M | $3.14M | $12.22M | $11.19M | $4.55M |
| Net Profit | -$28.46M | -$4.89M | $330.96M | -$713.41M | -$412.23M |
| Profit from Continuing Operations | -$28.46M | -$4.89M | $330.96M | -$713.41M | -$412.23M |
| Net Income to Parent Company | -$28.46M | -$4.89M | $330.96M | -$713.41M | -$412.23M |
| Net Income to Common Stockholders | -$28.46M | -$4.89M | $330.96M | -$713.41M | -$412.23M |
| Basic EPS | -$0.27 | -$0.05 | $3.15 | -$7.13 | -$3.93 |
| Diluted EPS | -$0.27 | -$0.05 | $2.88 | -$7.13 | -$3.93 |
| -Less:Other Special Charges | – | $39.00M | – | -$16.86M | -$13.10M |
| -Less:Write Off | – | – | – | $0.00 | – |
Balance sheet
| Line item | 2026 Q3 | 2026 Q2 | 2026 Q1 | 2025 ANNUAL | 2025 Q4 |
|---|---|---|---|---|---|
| Total Assets | $3.17B | $3.19B | $3.18B | $3.35B | $3.35B |
| Total Current Assets | $2.27B | $2.22B | $2.31B | $2.54B | $2.54B |
| Cash and Cash Equivalents & Short-Term Investments | $878.78M | $788.49M | $653.19M | $939.65M | $939.65M |
| -Cash and Cash Equivalents | $472.76M | $571.15M | $464.45M | $801.28M | $801.28M |
| -Short Term Investments | $406.02M | $217.34M | $188.74M | $138.37M | $138.37M |
| Receivables | $427.48M | $438.81M | $547.91M | $519.61M | $519.61M |
| -Accounts Receivable | $369.18M | $376.82M | $394.82M | $398.23M | $398.23M |
| -Accrued Interest Receivable | $2.99M | $3.49M | $2.62M | $1.66M | $1.66M |
| -Taxes Receivable | $13.81M | $13.49M | $14.03M | $15.60M | $15.60M |
| -Other Receivables | $41.50M | $45.02M | $136.45M | $104.12M | $104.12M |
| Prepaid Assets | $85.56M | $77.50M | $102.44M | $154.73M | $154.73M |
| Inventory | $876.12M | $904.27M | $1.00B | $914.74M | $914.74M |
| Other Current Assets | $4.95M | $14.75M | $5.23M | $9.20M | $9.20M |
| Total Non-Current Assets | $893.18M | $964.69M | $869.06M | $811.77M | $811.77M |
| Net PPE | $437.00M | $446.84M | $460.30M | $470.62M | $470.62M |
| -Gross PPE | $437.00M | $446.84M | $460.30M | $751.54M | $751.54M |
| Investments and Advances | $114.64M | $151.72M | $89.73M | $10.57M | $10.57M |
| Non-Current Prepaid Assets | $93.82M | $91.03M | $92.73M | $95.95M | $95.95M |
| Goodwill and Other Intangible Assets | $29.83M | $30.61M | $31.38M | $28.95M | $28.95M |
| Non-Current Deferred Assets | $2.85M | $2.86M | $2.81M | $2.82M | $2.82M |
| Other Non-Current Assets | $215.04M | $241.62M | $192.11M | $202.86M | $202.86M |
| Total Liabilities | $1.64B | $1.66B | $1.67B | $2.21B | $2.21B |
| Total Current Liabilities | $656.35M | $502.91M | $499.16M | $1.10B | $1.10B |
| Payables | $55.92M | $60.29M | $84.17M | $285.60M | $285.60M |
| -Accounts Payable | $45.70M | $50.98M | $70.38M | $280.84M | $280.84M |
| -Total Tax Payable | $10.22M | $9.31M | $13.79M | $4.76M | $4.76M |
| Current Accrued Expenses | $156.64M | $156.31M | $141.42M | $178.78M | $178.78M |
| Short-Term Debt and Capital Lease Obligation | $157.97M | – | – | $11.39M | $11.39M |
| -Current Debt | $157.97M | – | – | – | – |
| Current Provisions | $109.10M | $118.64M | $114.29M | $117.52M | $117.52M |
| Current Deferred Liabilities | $104.89M | $110.13M | $116.04M | $443.40M | $443.40M |
| Other Current Liabilities | $26.03M | $16.56M | $10.38M | – | – |
| Total Non-Current Liabilities | $980.86M | $1.16B | $1.17B | $1.11B | $1.11B |
| Long Term Debt and Capital Lease Obligation | $895.06M | $1.05B | $1.04B | $1.03B | $1.03B |
| -Long Term Debt | $699.39M | $847.62M | $838.16M | $828.97M | $828.97M |
| -Long Term Capital Lease Obligation | $195.66M | $198.23M | $198.51M | $199.38M | $199.38M |
| Non-Current Deferred Liabilities | $83.91M | $110.13M | $136.35M | $83.91M | $83.91M |
| Other Non-Current Liabilities | $1.89M | $1.83M | $1.65M | $1.53M | $1.53M |
| Total Equity | $1.53B | $1.53B | $1.51B | $1.14B | $1.14B |
| Stockholders' Equity | $1.53B | $1.53B | $1.51B | $1.14B | $1.14B |
| Capital Stock | $11,000.00 | $11,000.00 | $11,000.00 | $11,000.00 | $11,000.00 |
| -Common Stock | $11,000.00 | $11,000.00 | $11,000.00 | $11,000.00 | $11,000.00 |
| -Preferred Stock | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| Additional Paid-In Capital | $6.13B | $6.10B | $6.08B | $6.04B | $6.04B |
| Retained Earnings | -$4.58B | -$4.55B | -$4.55B | -$4.88B | -$4.88B |
| Less: Treasury Stock | -$25.01M | -$25.26M | -$25.26M | -$25.26M | -$25.26M |
| Gains/Losses Not Affecting Retained Earnings | -$1.59M | -$565,000.00 | -$121,000.00 | $272,000.00 | $272,000.00 |
| -Accumulated Depreciation | – | – | – | -$280.92M | -$280.92M |
| -Other Intangible Assets | – | – | – | $28.95M | $28.95M |
| -Current Capital Lease Obligation | – | – | – | $11.39M | $11.39M |
Cash flow
| Line item | 2026 Q3 | 2026 Q2 | 2026 Q1 | 2025 ANNUAL | 2025 Q4 |
|---|---|---|---|---|---|
| Operating Cash Flow | $59.97M | $197.07M | -$202.68M | -$205.48M | $131.21M |
| Net cash flow from continuing operations | $59.97M | $197.07M | -$202.68M | -$205.48M | $131.21M |
| Net Income from Continuing Operations | -$28.46M | -$4.89M | $330.96M | -$713.41M | -$412.23M |
| Gain/Loss from Continuing Operations | $3.82M | $3.66M | $4.82M | $14.38M | -$10.45M |
| Depreciation & Depletion & Amortization | $5.90M | $10.41M | $10.59M | $44.52M | $5.25M |
| Other Non-Cash Items | $12.60M | $9.38M | $8.32M | $70.59M | $14.23M |
| Change in Working Capital | $40.40M | $143.34M | -$586.25M | $78.04M | $339.51M |
| -Change in Receivables | $7.65M | $17.99M | $3.42M | $203.76M | -$2.49M |
| -Change in Inventory | $59.64M | $39.91M | -$69.76M | -$301.09M | $18.48M |
| -Change in Prepaid Assets | -$15.90M | $25.79M | $43.49M | $78.84M | $11.77M |
| -Change in Payables and Accrued Expense | $3.80M | $3.30M | -$270.49M | $104.27M | $249.62M |
| -Change in Other Current Assets | $19.32M | $82.39M | -$14.55M | -$79.78M | $20.29M |
| -Change In Other Working Capital | -$31.47M | -$32.13M | -$274.92M | $72.05M | $41.86M |
| Net cash flow from investing | -$158.35M | -$93.37M | -$134.39M | $69.64M | $96.21M |
| Net Cash Flow from Continuing Investing Activities | -$158.35M | -$93.37M | -$134.39M | $69.64M | $96.21M |
| Net PPE Purchase and Sale | -$2.93M | -$555,000.00 | -$2.08M | -$101.97M | -$3.59M |
| Net Intangibles Purchase and Sale | -$3.20M | $0.00 | -$1.00M | -$7.88M | -$796,000.00 |
| Net Investment Purchase and Sale | -$152.22M | -$92.82M | -$131.31M | $5.39M | $100.59M |
| Financing Cash Flow | $0.00 | $0.00 | $241,000.00 | -$168.34M | -$39.21M |
| Net Cash Flow from Continuing Financing Activities | $0.00 | $0.00 | $241,000.00 | -$168.34M | -$39.21M |
| Net Issuance Payments Of Debt | $0.00 | $0.00 | $0.00 | -$162.59M | -$39.26M |
| Net Common Stock Issuance | $0.00 | – | – | -$5.01M | $0.00 |
| Proceeds from Stock Option Exercised | $0.00 | $0.00 | $241,000.00 | $18.70M | $308,000.00 |
| Ending Cash Balance | $482.89M | $581.27M | $477.58M | $814.41M | $814.41M |
| Net Change in Cash | -$98.39M | $103.70M | -$336.83M | -$304.18M | $188.21M |
| Beginning Cash Balance | $581.27M | $477.58M | $814.41M | $1.12B | $626.20M |
| Free Cash Flow | $53.83M | $196.52M | -$205.76M | -$315.33M | $126.82M |
| -Change in Other Current Liabilities | – | $6.08M | -$3.44M | – | – |
| Net Business Purchase and Sale | – | – | $0.00 | $174.10M | $0.00 |
| Net Other Financing Charges | – | – | – | -$19.45M | -$261,000.00 |
No comments yet — be the first to weigh in on SRPT.
Sign in to join the discussion.